Class 2 Medicines Recall: Kyowa Kirin Limited, Abstral 200 microgram sublingual tablets
Kyowa Kirin Limited is recalling a specific batch as a precautionary measure, due to the reports of double tablets in a single blister pocket. This was identified during reference sample inspection an (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 29, 2020 Category: Drugs & Pharmacology Source Type: news

Fentanyl Sublingual Tablets Versus Subcutaneous Morphine for the Management of Severe Cancer Pain Episodes in Patients Receiving Opioid Treatment: A Double-Blind, Randomized, Noninferiority Trial
This research article has led to a Practice Changing Update on DynaMed Plus. It found that sublingual fentanyl may be as effective as subcutaneous morphine for pain reduction at 30 minutes in adults with cancer and severe pain episodes (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 5, 2017 Category: Consumer Health News Source Type: news

Galena settles U.S. kickback charges related to opioid drug
(Reuters) - Galena Biopharma Inc will pay more than $7.55 million to resolve charges it paid kickbacks to doctors to induce them to prescribe its opioid-based pain medication Abstral to patients, the U.S. Department of Justice said on Friday. (Source: Reuters: Health)
Source: Reuters: Health - September 8, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Abstral (Fentanyl Sublingual Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 24, 2017 Category: Drugs & Pharmacology Source Type: news

Subsys (Fentanyl Sublingual Spray) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 6, 2017 Category: Drugs & Pharmacology Source Type: news